SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029396
Filing Date
2019-08-06
Accepted
2019-08-06 16:30:47
Documents
46
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20190630.htm   iXBRL 10-Q 1687934
2 EX-31.1 wve-ex311_7.htm EX-31.1 14715
3 EX-31.2 wve-ex312_8.htm EX-31.2 15041
4 EX-32 wve-ex32_6.htm EX-32 8853
5 GRAPHIC gxzwgcyefip4000001.jpg GRAPHIC 43965
  Complete submission text file 0001564590-19-029396.txt   4259889

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wve-20190630.xsd EX-101.SCH 33393
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20190630_cal.xml EX-101.CAL 42160
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20190630_def.xml EX-101.DEF 73350
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20190630_lab.xml EX-101.LAB 261284
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20190630_pre.xml EX-101.PRE 179011
11 EXTRACTED XBRL INSTANCE DOCUMENT wve-10q_20190630_htm.xml XML 380142
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 191002508
SIC: 2834 Pharmaceutical Preparations